Skip to main content

Table 3 LPS + Nigericin stimulation of peripheral blood mononuclear cells from patients with severe asthma, Spearman correlation coefficients between IL-1β release and key clinical characteristics

From: Characterization and inhibition of inflammasome responses in severe and non-severe asthma

 

LPS (2 h) + 

Nigericin (1 h)

LPS (4 h) + Nigericin (1 h)

BMI

r = − 0.13

P = 0.436

r = − 0.27

P = 0.113

ACQ-6, mean

r = 0.12

P = 0.489

r = − 0.00

P = 0.980

Sputum eosinophils, %

r = − 0.17

P = 0.456

r = 0.26

P = 0.247

Sputum eosinophils, total

r = 0.46

P = 0.043

r = 0.55

P = 0.012

Sputum neutrophils, %

r = 0.40

P = 0.067

r = 0.18

P = 0.415

Sputum neutrophils, total

r = 0.48

P = 0.032

r = 0.33

P = 0.158

FEV1preb2pp

r = 0.17

P = 0.339

r = 0.12

P = 0.478

FVCpreb2pp

r = 0.13

P = 0.473

r = 0.14

P = 0.435

FEV1/FVC, %

r = 1.00

P = 0.568

r = 0.06

P = 0.741

  1. ACQ-6 Asthma Control Questionnaire-6, BMI Body Mass Index, FEV1preb2pp Pre-Bronchodilator % Predicted FEV1, FVCpreb2pp Pre-Bronchodilator % Predicted FVC, LPS Lipopolysaccharide, r Spearman rho